Targeting Nerve Growth Factor (NGF) for Pain Management: What Does the Future Hold for NGF Antagonists? Bernard BannwarthMarie Kostine Current Opinion 02 April 2014 Pages: 619 - 626
First-Line Treatment of Newly Diagnosed Elderly Patients with Chronic Myeloid Leukemia: Current and Emerging Strategies Gabriele GugliottaFausto CastagnettiGianantonio Rosti Review Article 08 April 2014 Pages: 627 - 643
Early Versus Delayed Initiation of Pharmacotherapy in Parkinson’s Disease Matthias LöhleCarl-Johan RambergAnthony H. V. Schapira Review Article 23 April 2014 Pages: 645 - 657
Teriflunomide and Its Mechanism of Action in Multiple Sclerosis Amit Bar-OrAndrew PachnerHeinz Wiendl Review Article Open access 17 April 2014 Pages: 659 - 674
Trastuzumab Emtansine: A Review of Its Use in Patients with HER2-Positive Advanced Breast Cancer Previously Treated with Trastuzumab-Based Therapy Sohita Dhillon Adis Drug Evaluation 22 March 2014 Pages: 675 - 686
Elvitegravir: A Review of Its Use in Adults with HIV-1 Infection Emma D. Deeks Adis Drug Evaluation 27 March 2014 Pages: 687 - 697
Degarelix: A Review of Its Use in Patients with Prostate Cancer Natalie J. CarterSusan J. Keam Adis Drug Evaluation 23 April 2014 Pages: 699 - 712
Elosulfase alfa: First Global Approval Mark SanfordJin Han Lo R&D Insight Report 04 April 2014 Pages: 713 - 718